Action 300573 SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Shenyang Xingqi Pharmaceutical Co.,Ltd.

Actions

300573

CNE100002DV1

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 07/05/2024 		Varia. 5j. Varia. 1 janv.
269,9 CNY +4,62% Graphique intraday de Shenyang Xingqi Pharmaceutical Co.,Ltd. +3,99% +48,05%
26/04 Les bénéfices de Shenyang Xingqi Pharmaceutical pour le premier trimestre augmentent de 80 MT
25/04 Shenyang Xingqi Pharmaceutical Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Shenyang Xingqi Pharmaceutical's Q1 Profit Jumps 80%
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Xingqi Pharma Gets Nod to Market Atropine Sulfate Eye Drop; Shares Up 3%
Shenyang Xingqi Pharmaceutical Co.,Ltd. Approves Board Elections
Shenyang Xingqi Pharmaceutical Co.,Ltd.(SZSE:300573) added to Shenzhen Stock Exchange Component Index
Shenyang Xingqi Pharmaceutical Co.,Ltd.(SZSE:300573) added to Shenzhen Stock Exchange Component A Share Index
Xingqi Pharmaceutical's Diquafosol Sodium Eye Drops Bags China's Centralized Drug Bid
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Shenyang Xingqi Pharmaceutical Co.,Ltd. Announces Interim Dividend on A Shares for the Year 2023, Payable on 22 September 2023
Shenyang Xingqi Pharmaceutical Co.,Ltd Approves Cash Interim Profit Distribution Plan for 2023
Shenyang Xingqi Pharmaceutical Co.,Ltd. Proposes Interim Dividend for the First Half of 2023
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Xingqi Pharmaceutical Enrolls First Subject for Phase 4 Trial of Eye Drops
Shenyang Xingqi Pharmaceutical Co.,Ltd Approves Cash Dividend for the Year 2022, Payable on 22 May 2023
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Shenyang Xingqi Pharmaceutical Co.,Ltd Proposes Final Dividend for 2022
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Shenyang Xingqi Pharmaceutical Co.,Ltd Announces Interim Dividend on A Shares for the Year 2021, Payable on September 23, 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 300573
  4. Actualités Shenyang Xingqi Pharmaceutical Co.,Ltd.
  5. Autres langues